Evidence map›Paper›PMID 27655778›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2016

(MYO)SLIDing Our Way Into the Vascular Pool of Long Noncoding RNAs.

Francisco J Naya, Da-Zhi Wang

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Francisco J NayaFrom the Department of Biology, Boston University, MA (F.J.N.); and Department of Cardiology, Boston Children's Hospital, Harvard Medical School, MA (D.-Z.W.).
Da-Zhi WangFrom the Department of Biology, Boston University, MA (F.J.N.); and Department of Cardiology, Boston Children's Hospital, Harvard Medical School, MA (D.-Z.W.). dwang@enders.tch.harvard.edu.

Funding

MEF2 Function in Cardiac Muscle DevelopmentR01HL073304 · NHLBI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI NAYA, FRANCISCO J · 2003 to 2013
$3.3M
MicroRNAs, cardiac development and functionR01HL085635 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WANG, DA-ZHI · 2007 to 2015
$3.2M
Therapeutic applications of miRNAs in myocardial and cardiac regenerationR01HL125925 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI WANG, DA-ZHI · 2016 to 2019
$1.8M
Molecular Mechanisms of Dilated CardiomyopathyR01HL116919 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI WANG, DA-ZHI · 2013 to 2016
$1.7M
Transcriptional control of cardiac developmentR01HL075251 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WANG, DA-ZHI · 2004 to 2007
$1.1M
NHLBI NIH HHS R01 HL073304NHLBI NIH HHS R01 HL075251NHLBI NIH HHS R01 HL085635NHLBI NIH HHS R01 HL116919NHLBI NIH HHS R01 HL125925
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RNA, Long NoncodingRNA, UntranslatedMicroRNAsMicroRNAsRNA, Long NoncodingRNA, UntranslatedatherosclerosismicroRNAsmyocytes, cardiacserum response factortransforming growth factor beta

Identifiers

PMID27655778
PMCPMC5108579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.